SelectQuote Inc. is a technology-driven insurance brokerage that specializes in providing personalized insurance solutions to consumers. The company connects individuals with various insurance options, including life, health, and auto insurance, by utilizing a robust online platform and a dedicated team of licensed agents. Through their innovative services, SelectQuote aims to simplify the insurance shopping process, helping clients find the best coverage that meets their unique needs and budget. By leveraging technology and a wide network of insurance carriers, SelectQuote seeks to empower customers with informed choices regarding their insurance needs. Read More
NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Novo Nordisk A/S (NYSE:NVO), Altimmune, Inc. (NASDAQ:ALT), SelectQuote, Inc. (NYSE:SLQT) and Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
Shares of SelectQuote are trading sharply higher Thursday afternoon. The company announced Q4 revenue of $345.1 million, beating the consensus estimate.
NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against SelectQuote, Inc. (“SelectQuote” or the “Company”) (NYSE: SLQT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
SelectQuote (SLQT) reported Q4 revenue of $345.1M, beating estimates. EPS improved to -$0.17. Strong Healthcare Services growth drove a return to net income.
NEW ORLEANS, Aug. 20, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 10, 2025 to file lead plaintiff applications in a securities class action lawsuit against SelectQuote, Inc. (“SelectQuote” or the “Company”) (NYSE: SLQT), if they purchased the Company’s securities between September 9, 2020 and May 1, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In SelectQuote To Contact Him Directly To Discuss Their Options
NEW YORK and NEW ORLEANS, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 10, 2025 to file lead plaintiff applications in a securities class action lawsuit against SelectQuote, Inc. (“SelectQuote” or the “Company”) (NYSE: SLQT), if they purchased the Company’s securities between September 9, 2020 and May 1, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
NEW YORK, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of SelectQuote, Inc. (“SelectQuote” or the “Company”) (NYSE: SLQT) between September 9, 2020 and May 1, 2025, inclusive.
NEW YORK, NY - August 17, 2025 ( NEWMEDIAWIRE ) - Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against SelectQuote, Inc. (“SelectQuote” or “the Company”) (NYSE: SLQT) and certain of its officers.
NEW YORK, Aug. 16, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Novo Nordisk A/S (NYSE:NVO), Altimmune, Inc. (NASDAQ:ALT), SelectQuote, Inc. (NYSE:SLQT) and Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
